Loading chart…
PRE-MARKET
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules.
Gland Pharma Limited (GLAND) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The GLAND share price is ₹3,132.80 (-0.61% today), with a market capitalisation of ₹517B and a price-to-earnings (P/E) ratio of 41.8. MarketRipple tracks the GLAND investment thesis, the ripple-chain impact of market events on Gland Pharma Limited, and the Healthcare sector outlook.
Open
₹3,185.00
High
₹3,199.00
Low
₹3,082.20
Prev. Close
₹3,152.00
52W High
₹3,208.60
52W Low
₹1,573.60
Day range
₹3,082.20–₹3,199.00
52-week range
₹1,573.60–₹3,208.60
Volume
100K
P/E
41.8
ROE
9.9%
D/E
0.03
Margin
16.8%
Gland Pharma Limited (NSE: GLAND) is currently trading at ₹3,132.80 (-0.61%).
Gland Pharma Limited's market capitalization is ₹517B.
Gland Pharma Limited's price-to-earnings (P/E) ratio is 41.8.
Gland Pharma Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Gland Pharma Limited currently reads positive, based on 14 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.